Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Ottawa discovery provides new insight into blood development and leukemia
December 21, 2010
A new study by Dr. Marjorie Brand and colleagues reveals how a protein involved in the development of red blood cells can also promote the development of leukemia. The study shows that the protein TAL1 binds to different DNA sequences and activates different sets of genes in T-ALL leukemia cells compared to normal red blood precursor cells. The finding could help in the development of new therapies for leukemia and other blood disorders. See
EMBO
Journal for details.
Dr. Brand is a Senior Scientist at the Ottawa Hospital Research Institute (Regenerative Medicine Program, Sprott Centre for Stem Cell Research) and an Associate Professor at the University of Ottawa (Faculty of Medicine). She also holds a Canada Research Chair in the Regulation of Gene Expression